Comparative study of different ultrasound guided analgesic methods in radiofrequency ablation of benign thyroid nodules

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055676

Enrollment

Unknown

Registered

2022-01-16

Start date

2022-01-17

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid occupying lesions

Interventions

Group A:bilateral ultrasound-guided superficial cervical plexus nerve block before surgery

Group B:ultrasound-guided local anesthesia with step-by-step infiltration of the needle path.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. A single benign thyroid nodule; 2. Normal thyroid function; 3. Elective surgery requiring ultrasound-guided radiofrequency ablation of the thyroid gland; 4. Age 18-65 years; 5. ASA grade I-II.

Exclusion criteria

Exclusion criteria: 1. Coagulation dysfunction; 2. Infection at the puncture site; 3. Those who are allergic to ropivacaine; 4. Grade 2 or above severe hypertension; 5. Myocardial ischemic disease.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale (VAS) score;	—

Secondary

Measure	Time frame
40-item Recovery Quality Rating Scale, QoR-40 ;Opioid demand;Heart rate;Mean arterial pressure, MAP;	—

Countries

China

Contacts

Public ContactWang Xiao

The First Affiliated Hospital of Xiamen University

150857532@qq.com+86 13600940087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026